| Committee Member | Employment | Consultant | Speakers Bureau | Ownership/Partnership/Principal | Personal Research | Institutional, Organizational, or Other Financial Benefit | Expert Witness |
|---|---|---|---|---|---|---|---|
| Eric M. Isselbacher (Chair) | Massachusetts General Hospital–Director, Healthcare Transformation Lab; Co-Director, MGH Thoracic Aortic Center; Harvard Medical School–Associate Professor of Medicine | None | None | None | None | None | None |
| James Hamilton Black III (Vice Chair) | Johns Hopkins Medicine–Professor of Surgery | None | None | None | None | None | None |
| Ourania Preventza (Vice Chair) | Baylor College of Medicine; Baylor St. Luke’s Medical Center–Professor of Surgery, Division of Cardiothoracic Surgery | ■ Terumo Aortic (Bolton Medical) ■ W.L. Gore & Associates |
None | None | None | None | None |
| John G. Augoustides | University of Pennsylvania–Professor, Department of Anesthesiology and Critical Care | None | None | None | None | None | None |
| Adam W. Beck | University of Alabama at Birmingham–Professor and Director of Vascular Surgery and Endovascular Therapy, Department of Surgery | ■ Cook Medical ■ Cryolife ■ Endologix ■ Philips ■ Terumo Aortic (Bolton Medical) |
None | None | ■ Cook Medical ■ Medtronic ■ Terumo Aortic (Bolton Medical) ■ W.L. Gore & Associates |
None | None |
| Michael A. Bolen | Cleveland Clinic, Main Campus–Associate Professor of Radiology, Division of Radiology | None | None | None | None | None | None |
| Alan C. Braverman | Washington University School of Medicine–Alumni Endowed Professor in Cardiovascular Diseases; Director, Marfan Syndrome and Aortopathy Clinic Cardiovascular Division, Department of Medicine | None | None | None | None | None | None |
| Bruce E. Bray | University of Utah–Professor, Department of Internal Medicine and Biomedical Informatics | None | None | None | None | None | None |
| Maya M. Brown-Zimmerman | Patient advocate | None | None | None | None | None | None |
| Edward P. Chen | Duke University Medical Center–Professor and Division Chief, Division of Cardiovascular and Thoracic Surgery | None | None | None | ■ Bolton Medical* | ■ Bolton Medical† | None |
| Tyrone J. Collins | Ochsner Medical Center–Section Head, Interventional Cardiology, Co-Director, Cardiac Catheterization Laboratory, Department of Interventional Cardiology | ■ InspireMD | None | None | None | ■ W.L. Gore & Associates† | None |
| Abe DeAnda Jr | UTMB-Galveston–Professor and Chief, Division of Cardiovascular and Thoracic Surgery, Division of Surgery | None | None | None | None | None | None |
| Christina L. Fanola | University of Minnesota–Assistant Professor, Department of Cardiovascular Medicine | ■ Janssen Pharmaceuticals | None | None | None | None | None |
| Leonard N. Girardi | Weill Cornell Medicine–Professor and Chairman, Department of Cardiothoracic Surgery | None | None | None | None | None | None |
| Caitlin W. Hicks | Johns Hopkins University School of Medicine–Associate Professor of Surgery, Division of Surgery | None | None | None | None | None | None |
| Dawn S. Hui | University of Texas Health San Antonio–Associate Professor, Department of Cardiothoracic Surgery | None | None | None | ■ Astellas Pharma* | None | None |
| William Schuyler Jones | Duke University–Associate Professor of Medicine & Director of Cardiac Catheterization Laboratory, Division of Medicine/Cardiology | ■ Bayer‡ ■ Janssen Pharmaceuticals‡ |
None | None | ■ Boehringer Ingelheim ■ Bristol-Myers Squibb |
None | None |
| Vidyasagar Kalahasti | Cleveland Clinic–Assistant Professor, Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University; Director, Marfan Syndrome & Connective Tissue Disorder Clinic, Aortic Center, Heart, Vascular and Thoracic Institute | None | None | None | None | None | None |
| Karen M. Kim | University of Michigan–Assistant Professor, Department of Cardiac Surgery | None | None | None | None | None | None |
| Dianna M. Milewicz | University of Texas Health Science Center at Houston–President George H.W. Bush Chair of Cardiovascular Medicine Vice Chair, Department of Internal Medicine Director, Division of Medical Genetics Director, Division of Internal Medicine | None | None | None | None | None | None |
| Gustavo S. Oderich | The University of Texas Health Science Center at Houston, McGovern Medical School–Professor of Surgery and Chief of Vascular and Endovascular Surgery, Director of Aortic Center, Department of Cardio-Thoracic and Vascular Surgery | ■ Cook Medical ■ GE Healthcare ■ W.L. Gore & Associates |
None | None | ■ Cook Medical‡ ■ GE Healthcare‡ ■ W.L. Gore & Associates‡ |
■ Centerline Biomedical, Advisory Board Member* ■ Cook Medical† ■ Philips, Advisory Board Member ■ W.L. Gore & Associates† |
None |
| Laura Ogbechie | Baylor College of Medicine–Nurse Practitioner, Department of Cardiothoracic Surgery | None | None | None | None | None | None |
| Susan B. Promes | Penn State Health Hershey Medical Center–Professor and Chair, Department of Emergency Medicine | None | None | None | None | None | None |
| Elsie Gyang Ross | Stanford University School of Medicine–Assistant Professor, Department of Surgery and Medicine | None | None | None | None | None | None |
| Marc L. Schermerhorn | Beth Israel Deaconess Medical Center–George H. A. Clowes Jr. Professor of Surgery, Chief, Division of Vascular and Endovascular Surgery, Department of Surgery | None | None | None | None | ■ Medtronic, Scientific Advisory Board Member* ■ Philips, Scientific Advisory Board Member* |
None |
| Sabrina Singleton Times§ | American Heart Association/American College of Cardiology Guideline Advisor | None | None | None | None | None | None |
| Elaine E. Tseng | University of California San Francisco; San Francisco VA Medical Center–Professor of Surgery University of California San Francisco; Chief of Cardiothoracic Surgery, San Francisco VA Department of Surgery | None | None | None | None | ■ Cryolife†‡ | None |
| Grace J. Wang | University of Pennsylvania Hospital–Associate Professor of Surgery, Division of Vascular Surgery and Endovascular Therapy | None | None | None | None | None | None |
| Y. Joseph Woo | Stanford University–Chair, Division of Cardiothoracic Surgery | None | None | None | None | None | None |
This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency.
Relationships in this table are modest unless otherwise noted. According to the ACC/AHA, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document or makes a competing drug or device addressed in the document; or c) the person or a member of the person’s household, has a reasonable potential for financial, professional or other personal gain or loss as a result of the issues/content addressed in the document.
No financial benefit.
This disclosure was entered under the Clinical Trial Enroller category in the ACC’s disclosure system. To appear in this category, the author acknowledges that there is no direct or institutional relationship with the trial sponsor as defined in the (ACCF or AHA/ACC) Disclosure Policy for Writing Committees.
Significant relationship.
Sabrina Singleton Times is an AHA/ACC joint staff member and acts as the Guideline Advisor for the “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease.” No relevant relationships to report. Nonvoting author on measures and not included/counted in the RWI balance for this committee.
ACC indicates American College of Cardiology; ACCF, American College of Cardiology Foundation; AHA, American Heart Association; MGH, Massachusetts General Hospital; RWI, relationships with industry and other entities; UTMB, University of Texas Medical Branch; and VA, Veterans Affairs.